The success of Viagra initially sparked a surge for major pharmaceutical companies, nevertheless recent developments present a uncertain outlook for shareholders. Generic versions are eating into earnings, and https://macievute307094.mdkblog.com/47328168/the-blue-pill-and-the-pharmaceutical-industry-a-risky-investment